Abstract
Purpose
The purpose of this meta-analysis is to evaluate the effect of ethanol lock on the incidence of catheter-related bloodstream infection (CRBSI) in patients with central venous catheters.
Methods
RCTs comparing ethanol lock with another solution lock for prevention of CRBSI were obtained by searching databases of PubMed, Embase, Web of Science and Cochrane Central Register of clinical trials for eligible randomized controlled trials (inception to December 2017). Two researchers separately selected the RCTs and assessed their quality. Data on patient characteristics and ethanol protocols were collected. The primary outcome was the incidence of CRBSI, and the secondary outcomes were catheter colonization, exit infection and thrombosis.
Results
A total of 2575 patients with 3375 catheters from 7 eligible RCTs were included. Overall, ethanol lock significantly decreased the risk of CRBSI, with RR 0.54 (95% CI 0.38–0.78; I2 = 0%; p = 0.001); no obvious heterogeneity was observed in the fixed-effects model (I2 = 0%). Of note, subgroup analysis demonstrated that ethanol lock conferred significant benefit in studies with tunneled catheters (RR 0.46; 95% CI 0.30–0.72) but not in studies with untunneled catheters. Only two studies provided data regarding catheter colonization, and no significant difference was found (RR, 1.09; 95% CI, 0.87–1.38; I2 = 41%; p = 0.45). Moreover, pooled data did not show significant differences between ethanol and control groups with regard to the incidence of thrombosis (RR 1.05; 95% CI 0.91–1.22; I2 = 0%; p = 0.48).
Conclusions
Our meta-analysis suggests that ethanol lock is effective on reducing the incidence of CRBSI in hemodialysis patients with tunneled central venous catheters.
Similar content being viewed by others
Abbreviations
- RCTs:
-
Randomized controlled trials
- CVCs:
-
Central venous catheters
- CRBSI:
-
Catheter-related bloodstream infection
- RR:
-
Risk ratio
- CI:
-
Confidence interval
- WMD:
-
Weighted mean difference
- ARR:
-
Absolute risk reduction
References
Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45
Rosenthal VD, Guzman S, Migone O et al (2003) The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 31:475–480
Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584–1590
Siempos II, Kopterides P, Tsangaris I et al (2009) Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 37:2283–2289
Digiovine B, Chenoweth C, Watts C et al (1999) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160:976–981
Rello J, Ochagavia A, Sabanes E et al (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162:1027–1030
Goey SH, Verweij J, Bolhuis RL et al (1997) Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients. Cancer Immunol Immunother 44:301–304
Maki DG, Stolz SS, Wheeler S et al (1994) A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 22:1729–1737
Betjes MG (2011) Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol 7:257–265
Chatzinikolaou I, Finkel K, Hanna H et al (2003) Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 115:352–357
Safdar N, Maki DG (2006) Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43:474–484
Ramos ER, Reitzel R, Jiang Y et al (2011) Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39:245–251
Dixon JJ, Steele M, Makanjuola AD (2012) Anti-microbial locks increase the prevalence of staphylococcus aureus and antibiotic-resistant enterobacter: observational retrospective cohort study. Nephrol Dial Transplant 27:3575–3581
Balestrino D, Souweine B, Charbonnel N et al (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24:3204–3209
Qu Y, Istivan TS, Daley AJ et al (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442–450
Onland W, Shin CE, Fustar S et al (2006) Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 160:1049–1053
Oliveira C, Nasr A, Brindle M et al (2012) Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 129:318–329
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269
Sanders J, Pithie A, Ganly P et al (2008) A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 62:809–815
Slobbe L, Doorduijn JK, Lugtenburg PJ et al (2010) Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS ONE 5:e10840
Broom JK, Krishnasamy R, Hawley CM et al (2012) A randomized controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients–the healthy-cath trial. BMC Nephrol 13:146
Worth LJ, Slavin MA, Heath S et al (2014) Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: a randomized trial in adult haematology patients with Hickman devices. J Hosp Infect 88:48–51
Pérez-Granda MJ, Barrio JM, Munoz P et al (2014) Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial. PLoS ONE 9:e91838
Souweine B, Lautrette A, Gruson D et al (2015) Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med 191:1024–1032
Schoot RA, van Ommen CH, Stijnen T et al (2015) Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: a randomised controlled multi-centre trial. Eur J Cancer 51:2031–2038
Safdar N, O’Horo JC, Ghufran A et al (2014) Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*. Crit Care Med 42:1703–1713
Timsit JF, Bruneel F, Cheval C et al (1999) Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 130:729–735
Randolph AG, Cook DJ, Gonzales CA et al (1998) Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 26:1452–1457
Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777
Yahav D, Rozen-Zvi B, Gafter-Gvili A et al (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93
Ho KM, Litton E (2006) Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 58:281–287
Mermel LA, Alang N (2014) Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother 69:2611–2619
Schilcher G, Schlagenhauf A, Schneditz D et al (2013) Ethanol causes protein precipitation–new safety issues for catheter locking techniques. PLoS ONE 8:e84869
Abu-El-Haija M, Schultz J, Rahhal RM (2014) Effects of 70% ethanol locks on rates of central line infection, thrombosis, breakage, and replacement in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 58:703–708
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, T., Liu, H. & Han, J. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. Int Urol Nephrol 50, 1643–1652 (2018). https://doi.org/10.1007/s11255-018-1855-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1855-4